Isaac Manke insider trades

Open-market stock purchases and sales by Isaac Manke, Director at Addex Therapeutics Ltd, from SEC Form 4 filings since Mar 25, 2024.

Recent trades

DateStockTradeValue
Sep 2, 2026ADXN Addex Therapeutics LtdBought (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdSold (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdBought (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdSold (not open market)—
Aug 7, 2026OKUR OnKure Therapeutics, IncBought (not open market)—
Aug 7, 2026OKUR OnKure Therapeutics, IncSold (not open market)$278K
Aug 7, 2026OKUR OnKure Therapeutics, IncBought (not open market)$63.3K
Jun 30, 2026QTTB Q32 Bio IncBought (not open market)$150K
Jun 30, 2026QTTB Q32 Bio IncBought (not open market)—
Jun 12, 2026QTTB Q32 Bio IncBought (not open market)—
Jun 12, 2026QTTB Q32 Bio IncBought (not open market)—
Dec 31, 2025OKUR OnKure Therapeutics, IncBought (not open market)—
Oct 23, 2025QTTB Q32 Bio IncBought (not open market)—

Companies traded

  • ADXN Addex Therapeutics Ltd: other filings, last Sep 2, 2026
  • OKUR OnKure Therapeutics, Inc: other filings, last Aug 7, 2026
  • QTTB Q32 Bio Inc: other filings, last Jun 30, 2026

Get free alerts when Isaac Manke files a new trade →